Egor Kuzmin

Dr. Egor Kuzmin

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
Egor KuzminEgor Kuzmin
Egor Kuzmin
ZSZ. V. Shamitko
Z. V. Shamitko
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
MIM. Yu. Ivanova
M. Yu. Ivanova
SKSergey L. Kuznetsov
Sergey L. Kuznetsov
Inflammatory processes accompanied by damage to the cell bodies of neurons are combined into the group of neuroinflammation. At the molecular, cellular and tissue levels, neuroinflammation serves as a sanogenetic response to a variety of injuries, including post-traumatic conditions and neurodegeneration. However, inflammatory changes in long-lived cells such as neurons inevitably trigger a range of adverse effects. As a result, prognosis often depends on the severity of neuroinflammation. In this work, we review the spectrum of biomarkers involved in two key mechanisms of neuroinflammation: immune-mediated and mechanical injury, that have a potential clinical application: cytokines, neurospecific proteins and their proteolysis products, markers of oxidative stress, matrix metalloproteinases and endocrine parameters. Over the past decades, a significant pool of data on neuroinflammation biomarkers has been accumulated and continues to grow, but no consensus has been reached on the actual gradation of their clinical significance. Applied branches of medicine require further systematization of information on biomarkers of neuroinflammation for effective prognostic decisions.

15 March 2023 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
VKV. A. Kudryavtseva
V. A. Kudryavtseva
Egor KuzminEgor Kuzmin
Egor Kuzmin
AMA. V. Moiseeva
A. V. Moiseeva
MOM. S. Obelchakova
M. S. Obelchakova
PSP. A. Sinitsina
P. A. Sinitsina
SKSergey L. Kuznetsov
Sergey L. Kuznetsov
Acute cerebral circulation disorder is one of the most discussed issues in modern intensive care and neurology, as it is a severe condition, leading to disability or death of the patient, in the absence of immediate medical care. This review discusses general and specific biological markers of stroke, genetic markers of stroke, and current data on their diagnostic significance. The main mechanisms of brain tissue cell death in stroke, such as apoptosis, necrosis, ferroptosis, parthanatosis, sarmoptosis, autolysis, autophagy, oncosis, excitotoxic death are analyzed; the morphological features of the observed processes and their structural manifestations are reviewed. For each type of cell death in nervous tissue, the most frequently detected molecular markers are discussed: specific kinases, Toll-like receptors in the case of apoptosis; serine-threonine protein kinases, components of the polyubiquitin system detected in necrosis; transferrin 1 receptors, typical for ferroptosis; poly(ADP-ribose)-polymerase, whose activity increases in parthanatosis; slow Wallerian degeneration protein that accumulates during sarmoptosis; and other biomarkers characteristic of both individual types of nerve cell death and general pathological processes affecting the brain.

29 November 2023 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
Egor KuzminEgor Kuzmin
Egor Kuzmin
SKSergey L. Kuznetsov
Sergey L. Kuznetsov
Aim. We sought to assess the effects of exogenous Hsp70 (single subcutaneous low- and high-dose injections) on organ structure and functions in adult mice.Materials and methods. We randomized CD1 90-day-old male mice (n = 30) to three groups (10 mice per group). We injected the animals with single subcutaneous saline solution for Group 1 (control), low dose (500 μg/kg) of recombinant human Hsp70 (HspA1A) for Group 2, and high dose (5000 μg/kg) of the Hsp70 for Group 3. We examined the behavior of the mice on Day 3 after the injections (distance traveled, velocity, and bowel movement number). We lethalized the mice on Day 5 with further histological study and morphometrics of cerebral cortex, thymus, spleen, and liver. The statistics included one-factor ANOVA test with post hoc Tukey test.Results. All study groups exhibited no significant difference of behavioral parameters. Some liver sinusoids were wider in control group and Hsp70 500 μg/kg group comparing to Hsp70 5000 μg/kg group. We obtained also data for morphometrics: no difference was found for the number of neurons in ganglionic cerebral cortex, the lymphocytic cellularity difference between thymic cortex and medulla, the number of lymphocytes in white splenic pulp, and the number of hepatocyte nuclei in the liver. Red splenic pulp exhibited 1774,5 ± 24,8, 1623,0 ± 26,7, 1553,6 ± 47,0 macrophages for control, low-dose and high-dose groups, respectively (р < 0,0001). Tukey test showed a significant difference between control group and each of Hsp70 groups 500 μg/kg (р = 0,012) and 5000 μg/kg (р < 0,0001).Conclusion. Our study revealed no negative impact of subcutaneous Hsp70 administration at low and high doses on organ structure and functions in mice.

12 December 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
Ksenia Sergeevna PokidovaKsenia Sergeevna Pokidova
Ksenia Sergeevna Pokidova
Egor KuzminEgor Kuzmin
Egor Kuzmin
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
IIIlya Izmailov
Ilya Izmailov
SKSergey L. Kuznetsov
Sergey L. Kuznetsov
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, often linked to mutations in the FUS gene, leading to toxic protein aggregates. This study investigates the role of HSP70, a molecular chaperone, in mitigating neurodegeneration in FUS-ALS mouse models. Using quantitative immunofluorescence microscopy, we mapped cellular changes in the primary motor cortex of double transgenic FUS/HSP70 mice and compared them to single FUS-transgenic controls. Our results reveal that double transgenic mice exhibit significantly reduced neuronal damage and increased levels of mature neuronal (NeuN) and microglial (Iba1) markers, indicating a protective effect of HSP70. Intracellular HSP70 expression proved more effective than extracellular release, suggesting that targeted HSP70 delivery to neurons may offer a promising therapeutic avenue for ALS. This study underscores the potential of quantitative immunofluorescence for mapping neuroprotective pathways and highlights HSP70’s impact on mitigating FUS-related pathology in ALS.

3 September 2022 in Journal of Biophotonics
Verified
Journal Article
Open access
TLTatiana A. Lomanovskaya
Tatiana A. Lomanovskaya
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
VSVladislav Soldatov
Vladislav Soldatov
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
Egor KuzminEgor Kuzmin
Egor Kuzmin
AYAlexander N. Yatskovskiy
Alexander N. Yatskovskiy
We examined hematological changes influenced by the experimental hypervitaminosis A. The 3D confocal optical profilometer was applied for assessment of the erythrocytes' membrane structural changes influenced by an overdose of vitamin A. The blood smears were evaluated in terms of alterations of geometrical and optical parameters of erythrocytes for two groups of animals: oil base and retinol palmitate (n = 9 animals for each group). The results demonstrate that an overdose of retinol palmitate causes changes in the torus curvature and pallor of discocytes, their surface area and volume. The observed structural malformations of the shape of red blood cells become visible at the earlier preclinical stage of changes in animal state and behavior. With this in mind, the results of the study open a new area of research in the certain dysfunction diagnosis of red blood cells and have a great potential in the further development of new curative protocols.

24 May 2025 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
Ksenia Sergeevna PokidovaKsenia Sergeevna Pokidova
Ksenia Sergeevna Pokidova
Egor KuzminEgor Kuzmin
Egor Kuzmin
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
SKSergey L. Kuznetsov
Sergey L. Kuznetsov
Aim. To study morphological and developmental changes in the structure of mice’s limbic system, which overexpress 70 kDa heat shock proteins (HSP70) and co-express mutant fused-in-sarcoma (FUS) protein with amyotrophic lateral sclerosis (ALS).Materials and methods. The study was based on mice (n = 36; six for each group) of six lines either without FUS mislocalization: C57Bl/6 (wild-type); extracellular (HSP70out) or intracellular (HSP70in) overexpression of HSP70 family 1A protein; or with FUS mislocalization: transgenic mice with ALS-FUS (FUS[1-359]); and double transgenic animals (FUS[1-359]/HSP70out and FUS[1-359]/HSP70in). All FUS expressing mice were symptomatic with myasthenia up to limb paralysis in some animals. When the mice were 20 weeks old, they were killed by staining histological slides of their brain using hematoxylin and eosin, toluidine blue by Nissl, immunofluorescent antibodies for the neuronal nuclear marker (NeuN) of the caudoputamen, septal nuclei, and hippocampus, as well as glial fibrillar acid protein (GFAP), S100β protein, and synaptophysin for the hippocampus. The number of neurons and the number of cells with a positive reaction to antibodies were counted. The statistical processing included ANOVA and were compared with the results from the Tukey test for.Results. Statistically significant differences were observed for the FUS-expressing groups compared to FUS-negative groups: (1) a reduction in the number of neurons and NeuN+-cells in the caudoputamen and amygdala, especially for FUS[1-359]/HSP70out group; (2) an increase in the number of hyperchromic neurons in the subiculum, cornu Ammonis (CA1), and dentate gyrus, with a significantly greater increase for FUS[1-359] and FUS[1-359]/HSP70out groups compared to FUS[1-359]/HSP70in group; (3) an increase in the number of GFAP+and S100β+-cells in the hippocampus, with the most pronounced change for the FUS[1-359] and FUS[1-359]/HSP70out groups compared to с FUS[1-359]/HSP70in group.Conclusion. An overexpression of HSP70 family 1A protein and co-expression of mutant FUS protein in the cytoplasm is accompanied by mitigated neurodegeneration in the structure of the limbic system compared with the expression of mutant FUS protein alone.